Magellan LeadCare II - Interference Substances

LeadCare
®
II User's Guide B-3
Interference Substances
Tests were conducted by adding the potential interferences at the concentrations
listed below to bovine blood with elevated lead levels. Lead results for samples with
each potential interference did not differ statistically from lead results obtained on
unadultered samples.
The following substances at the following concentrations do NOT affect the results of
the LeadCare
®
II System:
• 5,5-Diphenylhydantoin (phenytoin), 100 µg/mL
• Acetominophen, 500 µg/mL
• Amoxicillin, 100 µg/mL
• Amphotericin, 50 µg/mL
• Arsenic III, 0.01 µg/mL
• Arsenic V, 0.005 µg/mL
• Carboplatin, 0.25 µg/mL
• Cephalexin (Keflex), 60 µg/mL
• Ciprofloxacin, 100 µg/mL
• Clondine, 100 µg/mL
• Cyclophosphamide, 500 µg/mL
• d-Amphetamine Sulfate, 100 µg/mL
• Diphenylhydramine Hydrochloride, 100 µg/mL
• Doxorubicin, 100 µg/mL
• Doxycycline, 100 µg/mL
• Erythromycin, 100 µg/mL
• Ferric chloride, 100 µg/mL
• Ferrous sulfate, 100 µg/mL
• Fexofenadine HCl (Allegra), 50 µg/mL
• Fluconazole (Diflucan), 100 µg/mL
• Gabapentin (Neurontin), 100 µg/mL
• Ganciclovir (AZT), 100 µg/mL
• Glyburide, 100 µg/mL
• Guanfacine, 100 µg/mL
• Hydroxyurea, 250 µg/mL
• Ibuprofen, 500 µg/mL
• Indinavir Hydrate, 100 µg/mL
• Isoniazid, 100 µg/mL
• Loratadine, 100 µg/mL
• Methyl Phenidate (Ritalin) HCl, 100 µg/mL
• Methotrexate, 60 µg/mL
• Metronidazole, 100 µg/mL
• Niacin, 100 µg/mL
• Nicotine , 10 µg/mL
• Nystatin, 100 µg/mL
• Penicillamine, 25 µg/mL
• Phenylephrine, 100 µg/mL
• Piperazine, 100 µg/mL
• Pseudoephedrine (guiafenesin), 100 µg/mL
• Pyridoxine, 100 µg/mL
• Riboflavin, 0.5 µg/mL
• Rifampicin, 100 µg/mL
• Sitagliptin, 100 µg/mL
• Thiamine, 50 µg/mL
• Trimethoprim, 100 µg/mL
• Valproic Acid, Na salt, 500 µg/mL
• Vitamin D3, 100 µg/mL